Losartan based treatment v atenolol based treatment for essential hypertension with signs of left ventricular hypertrophy*
| Outcomes | Losartan | Atenolol | RRR (95% CI) | NNT (CI) |
|---|---|---|---|---|
| *Abbreviations defined in glossary; RRR, NNT, and CI calculated from data in article. | ||||
| †Cardiovascular mortality, stroke, and myocardial infarction. | ||||
| Composite end point† | 11% | 13% | 12% (2 to 22) | 64 (36 to 418) |
| Stroke | 5% | 7% | 24% (11 to 36) | 61 (42 to 140) |
| New onset diabetes | 6% | 8% | 24% (12 to 36) | 52 (35 to 108) |
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
Technorati
Twitter
The EBN Online Journal Club offers readers the opportunity to participate in discussion about research articles and commentaries
from Evidence Based Nursing (EBN).
How to participate >>
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Online ISSN 1468-9618
Copyright © 2013 by the BMJ Publishing Group Ltd & The RCN Publishing Company Ltd
